Trials / Completed
CompletedNCT01222650
A Comparative Study of KSO-0400 in BPH Patients With LUTS
A Randomized, Double-blind, Placebo-controlled, Multicentre Study of KSO-0400 in BPH Patients With LUTS
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 400 (planned)
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the efficacy and safety of KSO-0400 compared to placebo for the treatment of LUTS caused by BPH.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KSO-0400 | |
| DRUG | KSO-0400 | |
| DRUG | Silodosin | |
| DRUG | Placebo |
Timeline
- First posted
- 2010-10-18
- Last updated
- 2011-07-04
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01222650. Inclusion in this directory is not an endorsement.